<strong>Seminar:  The Road Not Taken: Perspectives from 2 executives in the biopharmaceutical industry</strong>

<strong>Scott Alban, PhD, JD</strong>
Vice President and Head of Global Intellectual Property, AstraZeneca

<strong>Jarrod Borkat, MBA</strong>
Senior Director, Partnering & Strategy, MedImmune

<strong>September 14th, 2017; 1:00 PM – 2:00 PM, Virginia Tech Carilion Research Institute, R3012, 2 Riverside Circle, Roanoke, VA </strong>


<strong><img class=" size-medium wp-image-967 alignnone" src="http://info.vtc.vt.edu/best/wp-content/uploads/2017/09/JF1_9034.jpg" alt="JF1_9034" width="140" height="160" /></strong> Scott Alban (B.S., Ph.D., Virginia Tech) leads the global intellectual property team, which is accountable for developing and implementing intellectual property strategies across the business, supporting business development teams in the evaluation of new opportunities and ensuring R&D and commercial assets are appropriately protected.

<strong><img class=" size-medium wp-image-967 alignnone" src="http://info.vtc.vt.edu/best/wp-content/uploads/2017/09/Headshot_Jarrod.jpg" alt="Headshot_Jarrod" width="140" height="160" /></strong> Jarrod Borkat is an 18‐year veteran in the biopharmaceutical industry. He joined MedImmune in 2010, where he currently serves as Senior Director, Partnering & Strategy and is responsible for spinning out companies, based on MedImmune assets.

To view the event live, please click <a title="here" href="http://research.vtc.vt.edu/live-webcast/%20 ">here</a>.



